Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GC Biopharma receives a business license for the construction of a plasma fractionation plant and technology transfer in Indonesia 2023-06-02 08:35
GenEros to Present Promising Results of GEC255 Phase I Clinical Trial for Advanced NSCLC Patients with KRAS G12C Mutation 2023-06-01 22:15
Impact Therapeutics Entered into Global Partnership with Eikon Therapeutics to Develop and Commercialize PARP1 Selective Inhibitors 2023-06-01 20:30
Aravax doses first patient in Phase 2 peanut allergy clinical trials 2023-06-01 20:00
BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program (BMD-001) and IV-Formulated siRNA Data at BIO2023 International Conference 2023-06-01 20:00
Seegene Obtains IVDR Certification for 30 Diagnostic Assays 2023-06-01 19:00
Kombucha Continues to Trend! TCI Received the Golden Award at the Geneva International Exhibition of Inventions 2023-06-01 18:06
Xinhua Silk Road: Activity to promote TCM cultural exchanges and cooperation between China and Luxembourg completes success 2023-06-01 17:37
Xinhua Silk Road: Global co-op highlighted in tour of Chinese herbs firm to Indonesian embassy in China 2023-06-01 17:35
WuXi Biologics to Increase Manufacturing Capacity in Germany 2023-06-01 16:49
Mediso installs 100% cryogen-free 7T MRI at the University of Milano-Bicocca, Italy 2023-06-01 16:00
CBC GROUP RELEASES 2022 ESG REPORT 2023-06-01 10:00
Xinhua Silk Road: Chinese Lingzhi brand Longevity Valley promotes inheritance of a century-old national treasure to Brunei foreign envoys 2023-06-01 09:47
Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency 2023-06-01 04:24
Actinogen to present progress on Cognitive Impairment in Depression and Alzheimer's Disease Phase 2 trials at the BIO International Convention 2023-05-31 20:58
QBIOTICS TO PRESENT AT SACHS 9TH ANNUAL IMMUNO-ONCOLOGY INNOVATION FORUM AND THE BIO INTERNATIONAL CONVENTION 2023-05-31 19:00
Asieris' progress in MIBC receives renewed attention with its inclusion in ASCO 2023 2023-05-31 16:00
Yuhan Corporation and J INTS BIO inked a licensing agreement for a New Drug Candidate targeting HER2 NSCLC 2023-05-31 13:02
Waterdrop Inc. Announces Earnings Date Change: First Quarter 2023 Earnings Release Scheduled June 2, 2023 2023-05-31 11:19
Ascentage Pharma's Novel Drug Olverembatinib Recommended for a Breakthrough Therapy Designation in China for the Treatment of SDH-Deficient GIST, the Second BTD for the Drug 2023-05-31 10:20
1 83 84 85 86 87 801